Browse Category

NASDAQ:COL.B News 6 February 2026

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Coloplast A/S stock sinks nearly 8% as Medicare reimbursement change hits Kerecis outlook

Copenhagen, Feb 6, 2026, 13:07 CET — Regular session Shares of Coloplast A/S dropped almost 8% on Nasdaq Copenhagen Friday following a cut in its growth forecast for Kerecis, now expected to be about 10%, down from around 25%. The company blamed new U.S. Medicare reimbursement rules for the setback. By 13:07 CET, Coloplast B had slid 7.82% to 495.35…

Stock Market Today

  • Deinove SA (ALDEI.PA) Sees 13 Million Shares Traded Amid Volatility on EURONEXT
    February 6, 2026, 10:32 AM EST. Deinove SA (ALDEI.PA) topped EURONEXT's intraday volume charts Monday, with 13.01 million shares exchanging hands, more than double its average daily volume. The microcap biotech stock traded between €0.02 and €0.03, closing near €0.0265, reflecting heightened speculative interest amid thin liquidity. Deinove's market cap stands at roughly €1.13 million. Despite negative earnings per share and a high enterprise-to-sales ratio, increased volume signals short-term buying pressure above the 50-day average price of €0.02. Meyka AI assigns a 'Hold' rating and forecasts an upside potential to €0.05, although risks remain from ongoing cash burn and microcap volatility. Traders eye support at €0.01 and resistance near €0.44 in this cautious, high-risk environment.
Go toTop